ARVO is the largest and most respected eye and vision research organization in the world. Our members include nearly 12,000 researchers from over 75 countries.
Retina International (RI) is a global umbrella organization for patient-led charities and foundations who support research into rare, genetically inherited and age-related forms of retinal disease. These diseases cause progressive degeneration of the retina – a thin layer of tissue at the back of the eye that is essential for vision.
the Retinal Information Network, is a service of the Laboratory for the Molecular Diagnosis of Inherited Eye Diseases
Online Mendelian Inheritance in Man®
An Online Catalog of Human Genes and Genetic Disorders
The National Center for Biotechnology Information advances science and health by providing access to biomedical and genomic informati
GeneReviews, an international point-of-care resource for busy clinicians, provides clinically relevant and medically actionable information for inherited conditions in a standardized journal-style format, covering diagnosis, management, and genetic counseling for patients and their families. Each chapter in GeneReviews is written by one or more experts on the specific condition or disease and goes through a rigorous editing and peer review process before being published online.
The National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE®)
The Institut de la Vision is one of the most important research centers in Europe on eye diseases. It brings together in a single building researchers, clinicians and industrial partners in order to discover, test and develop treatments and technological innovations for the benefit of visually impaired patients.
The Genetic and Rare Diseases (GARD) Information Center is a program of the National Center for Advancing Translational Sciences (NCATS) and funded by two parts of the National Institutes of Health (NIH): NCATS and the National Human Genome Research Institute (NHGRI). GARD provides the public with access to current, reliable, and easy to understand information about rare or genetic diseases in English or Spanish.
CORDIS is the European Commission’s primary portal for results of EU-funded research projects.
EURORDIS-Rare Diseases Europe is a unique, non-profit alliance of 745 rare disease patient organisations from 65 countries that work together to improve the lives of the 30 million people living with a rare disease in Europe.
The Foundation Fighting Blindness (FFB) was established in 1971 by a passionate group of families driven to find treatments and cures for inherited retinal diseases that were affecting their loved ones. At that time, little was known about these blinding retinal degenerative diseases. Very little research was being done, and there were no clinical trials for potential treatments.
NORD, a 501(c)(3) organization, is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them. NORD, along with its more than 260 patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.
The mission of the American Academy of Ophthalmology is to protect sight and empower lives by serving as an advocate for patients and the public, leading ophthalmic education, and advancing the profession of ophthalmology.
Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.